1.
Hosp Community Psychiatry
; 35(4): 385-7, 1984 Apr.
Article
in English
| MEDLINE
| ID: mdl-6714951
Subject(s)
Hospitals, Psychiatric , Mental Disorders/drug therapy , Psychopharmacology/standards , Psychotropic Drugs/therapeutic use , Antidepressive Agents/therapeutic use , Bipolar Disorder/drug therapy , Depressive Disorder/drug therapy , District of Columbia , Humans , Lithium/blood , Schizophrenia/drug therapy
2.
Am J Psychiatry
; 138(2): 202-9, 1981 Feb.
Article
in English
| MEDLINE
| ID: mdl-6109455
ABSTRACT
Neuroleptics are the cornerstone for both the acute treatment and prevention of most schizophrenic episodes. The authors review the current practical information available for the clinical management of acute episodes and maintenance therapy, including dosage schedules, plasma level determinations, and side effects. All neuroleptics given in equivalent doses produce approximately the same degree of antipsychotic activity. The most common cause of treatment failure in acute psychosis is an inadequate dose, and the most common cause of relapse is patient noncompliance. Maintenance medication should be given at the lowest dose that will sustain improvement. The authors also discuss several new alternative drug treatments to neuroleptics.
Subject(s)
Antipsychotic Agents/therapeutic use , Schizophrenia/drug therapy , Acute Disease , Antipsychotic Agents/adverse effects , Antipsychotic Agents/blood , Double-Blind Method , Drug Administration Schedule , Dyskinesia, Drug-Induced/etiology , Humans , Research
3.
Am Fam Physician
; 17(4): 82-3, 86, 1978 Apr.
Article
in English
| MEDLINE
| ID: mdl-25577